Related Experiment Video
Updated: Jul 16, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Chondrosarcoma in a family with multiple hereditary exostoses
A Kivioja1, H Ervasti, J Kinnunen
1Department of Orthopaedics and Traumatology, Helsinki University Central Hospital, Finland.
The Journal of Bone and Joint Surgery. British Volume
|February 7, 2001
Summary
Multiple hereditary exostoses (MHE) patients face a higher risk of developing chondrosarcoma. This study identified an 8.3% risk in one family, emphasizing the need for regular patient monitoring.
Area of Science:
- Genetics
- Oncology
- Orthopedics
Background:
- Multiple hereditary exostoses (MHE) is an autosomal dominant skeletal disorder characterized by cartilage-capped bone growths.
- Genetic heterogeneity exists, with mutations in ext1, ext2, and ext3 genes implicated.
- The reported risk of malignant transformation to chondrosarcoma in MHE ranges from 0.6% to 2.8%.
Observation:
- A six-generation family study included 114 adult members, with 46 diagnosed with MHE.
- Four family members underwent surgery for chondrosarcoma, indicating a higher-than-reported risk.
- Two additional patients showed suspected malignancy, but histology confirmed benign findings.
Findings:
- Genetic linkage analysis localized the MHE-causing gene to chromosome 11.
- Molecular studies identified a guanine-to-thymine transversion in the ext2 gene.
- The observed malignant transformation risk in this family was 8.3%, significantly exceeding previous estimates.
Implications:
- Patients with MHE have a substantial risk of malignant transformation, necessitating informed consent and regular clinical surveillance.
- Early detection and management strategies are crucial for improving outcomes in MHE patients.
- Further research into the genetic and molecular mechanisms underlying MHE and its malignant potential is warranted.
Related Concept Videos
Sex-linked Disorders
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Bone Formation by Endochondral Ossification
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...

